Yonsei Criteria, a Potential Linkage to Intratumoral Foxp3 ⁺/CD8⁺ Ratio for the Prediction of Oncologic Outcomes in Resected Left-Sided Pancreatic Cancer.

CONCLUSION: Yonsei criteria may be clinically detectable biologic marker with which to predict immunologic status and survival in pancreatic cancer patients. PMID: 32233171 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32233171?dopt=Abstract

Source: Yonsei Medical Journal - March 31, 2020 Category: Universities & Medical Training Authors: Hwang HK, Lee SH, Kim HI, Kim SH, Choi J, Kang CM, Lee WJ Tags: Yonsei Med J Source Type: research